APA (7th ed.) Citation

Y, T., & R, L. RET Inhibitor SPP86 Is a Potential Candidate for the Clinical Treatment of Cutaneous Melanoma [Letter]. Dove Medical Press.

Chicago Style (17th ed.) Citation

Y, Tan, and Li R. RET Inhibitor SPP86 Is a Potential Candidate for the Clinical Treatment of Cutaneous Melanoma [Letter]. Dove Medical Press.

MLA (9th ed.) Citation

Y, Tan, and Li R. RET Inhibitor SPP86 Is a Potential Candidate for the Clinical Treatment of Cutaneous Melanoma [Letter]. Dove Medical Press.